Janux Therapeutics, Inc. (JANX)

NASDAQ: JANX · IEX Real-Time Price · USD

47.96

-2.59 (-5.12%)

At close: Apr 17, 2024, 4:00 PM

48.00

+0.04 (0.08%)

Pre-market: Apr 18, 2024, 4:24 AM EDT

Janux Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	2,478	495	549	821	-	-
Market Cap Growth	-	-9.72%	-33.17%	-	-	-
Enterprise Value	2,157	175	246	445	-8	3
PE Ratio	-8.50	-8.50	-8.70	-25.13	-	-
PS Ratio	306.52	61.29	63.71	225.73	-	-
PB Ratio	7.20	1.44	1.71	2.24	-	-
P/FCF Ratio	-9.45	-9.45	-11.11	-44.48	-	-
P/OCF Ratio	-9.80	-9.80	-12.78	-48.36	-	-
EV/Sales Ratio	266.90	21.66	28.59	122.47	-	-
EV/EBITDA Ratio	-3.11	-3.11	-3.96	-13.68	1.19	-0.89
EV/EBIT Ratio	-3.00	-3.00	-3.90	-13.63	1.19	-0.89
EV/FCF Ratio	-3.34	-3.34	-4.99	-24.13	1.79	-0.87
Debt / Equity Ratio	0.07	0.07	0.08	0.00	-	-0.50
Debt / EBITDA Ratio	-0.44	-0.44	-0.41	-0.01	-	-1.06
Debt / FCF Ratio	-0.47	-0.47	-0.51	-0.01	-	-1.04
Quick Ratio	26.46	26.46	19.86	29.36	4.97	0.14
Current Ratio	26.80	26.80	20.14	29.46	5.05	0.14
Asset Turnover	0.02	0.02	0.02	0.01	0	-
Interest Coverage	-	-	-	-	-31.93	-16.18
Return on Equity (ROE)	-17.90%	-17.90%	-18.70%	-11.80%	60.10%	-
Return on Assets (ROA)	-16.00%	-16.00%	-16.90%	-10.50%	-80.30%	-
Return on Capital (ROIC)	-19.78%	-19.78%	-19.39%	-8.98%	33.09%	95.61%
Earnings Yield	-2.35%	-11.77%	-11.49%	-3.98%	-	-
FCF Yield	-2.12%	-10.58%	-9.00%	-2.25%	-	-
Buyback Yield / Dilution	-6.14%	-6.14%	-76.24%	-2471.20%	-36.71%	-
Total Shareholder Return	-6.14%	-6.14%	-76.24%	-2471.20%	-36.71%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).